These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 28282359)

  • 21. Liver transplantation for hepatocellular carcinoma: single nodule with Child-Pugh class A sized less than 3 cm.
    Moon DB; Lee SG; Hwang S
    Dig Dis; 2007; 25(4):320-8. PubMed ID: 17960067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liver transplantation for recurrent hepatocellular carcinoma on cirrhosis after liver resection: University of Bologna experience.
    Del Gaudio M; Ercolani G; Ravaioli M; Cescon M; Lauro A; Vivarelli M; Zanello M; Cucchetti A; Vetrone G; Tuci F; Ramacciato G; Grazi GL; Pinna AD
    Am J Transplant; 2008 Jun; 8(6):1177-85. PubMed ID: 18444925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Harm and Benefits of Salvage Transplantation for Hepatocellular Carcinoma: An Updated Meta-analysis.
    Xiong Q; Geng TT; He L; Gao H
    Transplant Proc; 2016 Dec; 48(10):3336-3347. PubMed ID: 27931579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Salvage liver transplantation is a reasonable option for selected patients who have recurrent hepatocellular carcinoma after liver resection.
    Hu Z; Zhou J; Xu X; Li Z; Zhou L; Wu J; Zhang M; Zheng S
    PLoS One; 2012; 7(5):e36587. PubMed ID: 22574187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Salvage liver transplantation for recurrent hepatocellular carcinoma after liver resection: feasibility of the Milan criteria and operative risk.
    Kim BW; Park YK; Kim YB; Wang HJ; Kim MW
    Transplant Proc; 2008 Dec; 40(10):3558-61. PubMed ID: 19100437
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Infection with hepatitis C virus is an adverse prognostic factor after liver resection for early-stage hepatocellular carcinoma: implications for the management of hepatocellular carcinoma eligible for liver transplantation.
    Chirica M; Tranchart H; Tan V; Faron M; Balladur P; Paye F
    Ann Surg Oncol; 2013 Jul; 20(7):2405-12. PubMed ID: 23338483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The surgical challenges of salvage living donor liver transplantation for Hepatocellular carcinoma; The cumulative experience of 100 cases - A retrospective cohort study and a propensity score analysis.
    Yong CC; Elsarawy AM; Wang SH; Lin TS; Wang CC; Li WF; Lin TL; Kuo FY; Cheng YF; Chen CL; Lin CC
    Int J Surg; 2018 Jun; 54(Pt A):187-192. PubMed ID: 29723674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment for intrahepatic recurrence after curative resection of hepatocellular carcinoma: Salvage liver transplantation or re-resection/radiofrequency ablation? A Retrospective Cohort Study.
    Zhang X; Li C; Wen T; Peng W; Yan L; Yang J
    Int J Surg; 2017 Oct; 46():178-185. PubMed ID: 28890407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Curative Intent Treatment of Hepatocellular Carcinoma - 844 Cases Treated in a General Surgery and Liver Transplantation Center.
    Grigorie R; Alexandrescu S; Smira G; Ionescu M; Hrehoreţ D; Braşoveanu V; Dima S; Ciurea S; Boeţi P; Dudus I; Picu N; Zamfir R; David L; Botea F; Gheorghe L; Tomescu D; Lupescu I; Boroş M; Grasu M; Dumitru R; Toma M; Croitoru A; Herlea V; Pechianu C; Năstase A; Popescu I
    Chirurgia (Bucur); 2017; 112(3):289-300. PubMed ID: 28675364
    [No Abstract]   [Full Text] [Related]  

  • 30. Salvage liver transplantation for hepatocellular carcinoma recurrence after primary liver resection.
    Qu W; Zhu ZJ; Sun LY; Wei L; Liu Y; Zeng ZG
    Clin Res Hepatol Gastroenterol; 2015 Feb; 39(1):93-7. PubMed ID: 25150375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Salvage liver transplantation versus curative treatment for patients with recurrent hepatocellular carcinoma: A systematic review and meta-analysis.
    Liu J; Zhang G; Yang L; Yan D; Yu J; Wei S; Li J; Yi P
    Eur J Surg Oncol; 2024 Jul; 50(7):108427. PubMed ID: 38796968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pediatric liver transplantation for hepatocellular cancer and rare liver malignancies: US multicenter and single-center experience (1981-2015).
    Vinayak R; Cruz RJ; Ranganathan S; Mohanka R; Mazariegos G; Soltys K; Bond G; Tadros S; Humar A; Marsh JW; Selby RR; Reyes J; Sun Q; Haberman K; Sindhi R
    Liver Transpl; 2017 Dec; 23(12):1577-1588. PubMed ID: 28834194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiofrequency ablation of hepatocellular carcinoma as bridge therapy to liver transplantation: A 10-year intention-to-treat analysis.
    Lee MW; Raman SS; Asvadi NH; Siripongsakun S; Hicks RM; Chen J; Worakitsitisatorn A; McWilliams J; Tong MJ; Finn RS; Agopian VG; Busuttil RW; Lu DSK
    Hepatology; 2017 Jun; 65(6):1979-1990. PubMed ID: 28170115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resection for hepatocellular carcinoma is a good option in Child-Turcotte-Pugh class A patients with cirrhosis who are eligible for liver transplantation.
    Margarit C; Escartín A; Castells L; Vargas V; Allende E; Bilbao I
    Liver Transpl; 2005 Oct; 11(10):1242-51. PubMed ID: 16184539
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survival benefit of transplantation for recurrence of hepatocellular carcinoma after liver resection.
    Tuci F; Vitale A; D'Amico F; Gringeri E; Neri D; Zanus G; Bassi D; Polacco M; Boetto R; Lodo E; Germani G; Burra P; Angeli P; Cillo U
    Transplant Proc; 2014 Sep; 46(7):2287-9. PubMed ID: 25242770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relative net health benefit of liver resection, ablation, and transplantation for early hepatocellular carcinoma.
    Spolverato G; Vitale A; Ejaz A; Kim Y; Maithel SK; Cosgrove DP; Pawlik TM
    World J Surg; 2015 Jun; 39(6):1474-84. PubMed ID: 25665675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resection or transplantation for early hepatocellular carcinoma in a cirrhotic liver: does size define the best oncological strategy?
    Adam R; Bhangui P; Vibert E; Azoulay D; Pelletier G; Duclos-Vallée JC; Samuel D; Guettier C; Castaing D
    Ann Surg; 2012 Dec; 256(6):883-91. PubMed ID: 23108125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systematic review of efficacy and outcomes of salvage liver transplantation after primary hepatic resection for hepatocellular carcinoma.
    Chan DL; Alzahrani NA; Morris DL; Chua TC
    J Gastroenterol Hepatol; 2014 Jan; 29(1):31-41. PubMed ID: 24117517
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of pathological features of primary hepatocellular carcinoma on the outcomes of intrahepatic recurrence management: single center experience from Southern Taiwan.
    Ali MA; Li WF; Wang JH; Lin CC; Chen YJ; Lin TL; Lin TS; Lu SN; Wang CC; Chen CL
    HPB (Oxford); 2016 Oct; 18(10):851-860. PubMed ID: 27567971
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liver transplantation versus liver resection for the treatment of hepatocellular carcinoma.
    Lee KK; Kim DG; Moon IS; Lee MD; Park JH
    J Surg Oncol; 2010 Jan; 101(1):47-53. PubMed ID: 19798686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.